Lataa...
Circulating miR-23b as a Novel Biomarker for Early Risk Stratification After ST-Elevation Myocardial Infarction
BACKGROUND: miR-23b overexpression can promote cardiomyocyte apoptosis and reduce cell growth under hypoxic conditions, suggesting that miR-23b acts as a biomarker for ST-elevation myocardial infarction (STEMI). The aim of this study was to investigate the effect of miR-23b on STEMI patients. MATERI...
Tallennettuna:
| Julkaisussa: | Med Sci Monit |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
International Scientific Literature, Inc.
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5866732/ https://ncbi.nlm.nih.gov/pubmed/29535290 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12659/MSM.908060 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|